Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - ACCOUNTS PAYABLE
Accounts Payable ANVS - Annovis Bio, Inc.
1.29 M
LAST VALUE
37.07%
2 YEAR CAGR
80.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR